CVRX
NASDAQCVRx
$2.39
-3.55 (-59.76%)
2026-08-07 00:00
Healthcare
Medical Devices
--
--
Short Interest (1 Year)
% of Volume Sold ShortMarket Cap
$125.8M
P/E Ratio
N/A
52W Low
52W High
$2.30
$11.30
Volume
14.6M
Analyst Rating
Hold
Target: $11
10 Analyst Ratings
Strong Buy
0
Buy
0
Hold
10
Sell
0
Price Target Range
Low: $11
Avg: $11
High: $11
About CVRx
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular sy...
Employees
223
Website
cvrx.com
Financial Highlights
Annual
Quarterly
| Year | Revenue | Op Margin | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2025 | $56.7M | -90.5% | -$53.3M | -$39.6M |
| 2024 | $51.3M | -116.0% | -$60.0M | -$37.8M |
| 2023 | $39.3M | -109.7% | -$41.2M | -$38.4M |
| 2022 | $22.5M | -189.3% | -$41.4M | -$42.0M |
| 2021 | $13.0M | -199.2% | -$43.1M | -$26.5M |
| 2026 Q1 | $14.8M | -82.3% | -$13.1M | -$12.0M |
| 2025 Q4 | $16.0M | -69.8% | -$11.9M | -$9.7M |
| 2025 Q3 | $14.7M | -83.5% | -$12.9M | -$9.4M |
| 2025 Q2 | $13.6M | -105.8% | -$14.7M | -$7.8M |
| 2025 Q1 | $12.3M | -108.8% | -$13.8M | -$12.7M |
| 2024 Q4 | $15.3M | -67.0% | -$10.7M | -$8.0M |
| 2024 Q3 | $13.4M | -97.3% | -$13.1M | -$10.4M |
| 2024 Q2 | $11.8M | -118.3% | -$14.0M | -$9.5M |